Literature DB >> 30113429

Acute Pancreatitis in Chronic Dialysis Patients.

Mary Barbara1, Adrianne Tsen1, Laura Rosenkranz2.   

Abstract

The annual incidence of acute pancreatitis (AP) ranges from 4.9 to 73.4 cases per 100,000 worldwide. Patients with end-stage renal disease on dialysis have an increased risk for developing AP compared with patients without renal disease. In addition to the general population risk factors, there are factors related to renal insufficiency and dialysis process that might predispose to AP in this population. Clinical features and diagnosis are the same as those in patients without renal failure; however, amylase and lipase levels should be interpreted cautiously as they might be falsely elevated in renal failure. In this article, we will describe the risk factors that are exclusive to this population. In addition, we will also focus on the laboratory indices and clinical features that are unique to this population with patients with end-stage renal disease.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30113429     DOI: 10.1097/MPA.0000000000001119

Source DB:  PubMed          Journal:  Pancreas        ISSN: 0885-3177            Impact factor:   3.327


  3 in total

1.  Characteristics and clinical outcomes of patients over 80 years of age with acute pancreatitis.

Authors:  Enes Seyda Şahiner; Fatih Acehan; Osman Inan; Meryem Aslan; Emin Altiparmak; Ihsan Ateş
Journal:  Eur Geriatr Med       Date:  2022-03-04       Impact factor: 3.269

2.  Acute pancreatitis risk after kidney transplantation: Propensity score matching analysis of a national cohort.

Authors:  Ya-Wen Chuang; Shih-Ting Huang; Tung-Min Yu; Chi-Yuan Li; Mu-Chi Chung; Cheng-Li Lin; Chi-Sen Chang; Ming-Ju Wu; Chia-Hung Kao
Journal:  PLoS One       Date:  2019-09-11       Impact factor: 3.240

3.  Emodin Protects Against Acute Pancreatitis-Associated Lung Injury by Inhibiting NLPR3 Inflammasome Activation via Nrf2/HO-1 Signaling.

Authors:  Zhenming Gao; Jidong Sui; Rong Fan; Weikun Qu; Xuepeng Dong; Deguang Sun
Journal:  Drug Des Devel Ther       Date:  2020-05-21       Impact factor: 4.162

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.